GlassScriptPhysician profile
Timothy S Johnson
NPI 1801864343
$11,866.55
in general payments reported to CMS, 2019-2025
24 companies · $5,726 in 2025
The $5,726 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $859 · 2020: $2,087 · 2021: $1,214 · 2022: $1,275 · 2023: $146 · 2024: $559 · 2025: $5,726.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,500 · Food and Beverage: $1,129 · Travel and Lodging: $735 · Education: $67.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,500.00 |
| Food and Beverage | $1,129.17 |
| Travel and Lodging | $735.16 |
| Education | $67.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tigon Medical LLC | $4,500.00 | 2025 | |
| Supreme Orthopedic Systems, LLC | $3,445.16 | 2020-2024 | |
| Arthrex, INC. | $1,466.13 | 2019-2020 | |
| Zimmer Biomet Holdings, INC. | $1,092.32 | 2019-2025 | Oxford, Oxford Partial Knee |
| Stryker Corporation | $536.44 | 2019-2024 | Blueprint Patient Specific Instrumentation, Tornier Perform Reversed Augmented Glenoid, Tornier Perform Reversed Glenoid |
| Smith+Nephew, INC. | $186.86 | 2023-2025 | Bone Anchors With Arthroscopic Delivery System, Bioinductive Implant With Arthroscopic Delivery System - Medium, Acufex Director |
| Fx Shoulder Solutions, INC | $111.38 | 2024 | |
| Wright Medical Technology, INC. | $104.68 | 2019 | |
| Depuy Synthes Sales INC. | $64.41 | 2019-2024 | Peak, Monovisc, Orthovisc |
| Vericel Corporation | $49.10 | 2023-2024 | Maci |
| Horizon Therapeutics Plc | $44.62 | 2019 | |
| Innovation Technologies INC | $39.38 | 2023 | Irrisept |
| Anika Therapeutics, INC. | $35.26 | 2022 | |
| Pacira Therapeutics, INC. | $29.39 | 2019 | |
| Dynasplint Systems INC. | $28.51 | 2025 | Dynasplint |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $21.68 | 2025 | Chattanooga |
| Orthofix Medical, INC. | $19.56 | 2019-2020 | |
| Xiros INC | $17.03 | 2025 | |
| Abiomed | $16.70 | 2025 | |
| Fidia Pharma USA INC. | $16.12 | 2019 | |
| Bioventus LLC | $15.75 | 2019 | |
| Heron Therapeutics, INC. | $14.25 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $11.82 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.